Recurrence and new tumor development after frontline intravenous chemotherapy for retinoblastoma: Risk factors and treatment results.

Ahmet Kaan Gündüz Ibadulla MirzayevHandan DinçaslanFunda Seher Özalp Ateş

Published in: European journal of ophthalmology (2021)

Development of recurrence and/or NT after IVC was noted in 38% of all retinoblastoma eyes. Bilateral familial disease, LTBD >12 mm, and presence of subretinal seeds at baseline were risk factors for recurrence and NTs in this study.

Keyphrases

risk factors
free survival
optical coherence tomography
high dose
early onset
radiation therapy
case report
locally advanced
pulmonary embolism
rectal cancer
combination therapy
replacement therapy